SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,654.60 888.68
( 1.16%)

Global Indices

Nasdaq

52,776.51 545.43
(1.04%)

Dow Jones

7,451.65 17.47
(0.23%)

Hang Seng

61,006.88 -1,358.04
(-2.18%)

Nikkei 225

10,879.18 97.43
(0.90%)

Forex

USD-INR

95.97 -0.70
(-0.72%)

EUR-INR

109.29 -0.89
(-0.81%)

GBP-INR

127.84 -1.20
(-0.93%)

JPY-INR

0.59 0.00
(-0.81%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

163.1433353

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

45.01

1494.79

EPS(TTM)

Face Value()

Div & Yield %

20.08

0.03

Date	Headline
09-Jun-2026	Fredun Pharmaceuticals to convene AGM
29-May-2026	Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
25-May-2026	Board of Fredun Pharmaceuticals approves bonus issue of 2:1
25-May-2026	Board of Fredun Pharmaceuticals recommends final dividend
25-May-2026	Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
16-May-2026	Fredun Pharmaceuticals to announce Quarterly Result
29-Apr-2026	Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar
09-Apr-2026	Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrants
13-Feb-2026	Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter
31-Jan-2026	Fredun Pharmaceuticals to convene board meeting

<< < 1 2 > >>

77,654.60 888.68 ( 1.16%)

52,776.51 545.43 (1.04%)

7,451.65 17.47 (0.23%)

61,006.88 -1,358.04 (-2.18%)

10,879.18 97.43 (0.90%)

95.97 -0.70 (-0.72%)

109.29 -0.89 (-0.81%)

127.84 -1.20 (-0.93%)

0.59 0.00 (-0.81%)